Stuart C. Gordon, MD - Data-Driven Decision-Making in Primary Biliary Cholangitis: Evaluating the Expanding Evidence Base for PPAR Agonists
Update: 2025-11-19
Description
Visit https://www.peervoice.com/AEX860 to view the entire programme with slides. After completing “Stuart C. Gordon, MD - Data-Driven Decision-Making in Primary Biliary Cholangitis: Evaluating the Expanding Evidence Base for PPAR Agonists”, participants will be able to: Describe key efficacy and safety outcomes observed with use of PPAR agonists in specific subgroups of people with primary biliary cholangitis (PBC), including those with previous exposure to fibrates or obeticholic acid and those with compensated cirrhosis; Evaluate rates of biochemical response and alkaline phosphatase normalisation observed with novel PPAR agonists in individuals with PBC; and Assess the impact of novel PPAR agonists on pruritus and quality-of-life measures in individuals with PBC.
Comments
In Channel



